Skip to main navigation
Skip to search
Skip to main content
the UWA Profiles and Research Repository Home
Help & FAQ
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press / Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
The MTP inhibitor JTT-130 as a potential treatment for hyperlipidemia
John Burnett
Research output
:
Contribution to journal
›
Article
7
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The MTP inhibitor JTT-130 as a potential treatment for hyperlipidemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
diethyl 2-((3-dimethylcarbamoyl-4-((4'-trifluoromethylbiphenyl-2-carbonyl)amino)phenyl)acetyloxymethyl)-2-phenylmalonate
98%
Hyperlipidemias
44%
Japan
36%
Phase II Clinical Trials
26%
Tobacco
20%
Chemical Compounds
MTP Inhibitor
100%
Triglyceride
46%
Protein
18%